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Signal Fusion and Semantic Similarity Evaluation for Social Media 
Based Adverse Drug Event Detection 
Hameeduddin Irfan Khaja 
Recent advancements in pharmacovigilance tasks have shown the usage of social media 
as a resource to obtain real-time signals for drug surveillance. Researchers demonstrated a good 
potential for the detection of Adverse Drug Events (ADEs) using social media much earlier than 
the traditional reporting systems maintained by official regulatory authorities like the United 
States Food and Drug Administration (FDA). Existing automated drug surveillance systems have 
used various types of social media channels and search query logs for monitoring ADE signals. 
In this thesis, we address two key performance issues related to automated drug 
surveillance systems. The first is to improve the ADE signal detection by analyzing signals from 
multiple social media channels, and the second is usage of semantic similarity to evaluate ADE 
narratives detected by drug surveillance systems. Most current approaches for detecting ADEs 
from social media rely on a single channel: forums or microblogs or query logs. In this study we 
propose a new methodology to fuse signals from different social media channels. We use 
graphical causal models to discover potentially hidden connections between data channels, and 
then use such associations to generate signals for ADEs. Further, prior work have not emphasized 
much on the language of healthcare consumers, which is often casual and informal in expressing 
health issues on social media. There is a high potential to miss the semantic similarity between 
ADE terms extracted from social media and terms from formal official narratives when the two 
sets of terms do not share exact text. Thus, we exhibit the usage of semantic similarity to enhance 
accuracy of detected ADEs, and evaluated similarity measurement algorithms developed over 
biomedical vocabularies in ADE surveillance domain. We experimented on a dataset of drugs 
which had FDA black box warnings with a retrospective analysis spanning years 2008 to 2015. 
The results show a better detection rate and an improved performance in terms of precision, 
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1.1 Problem and Motivation  
 
According to the United States Federal Drug Administration (FDA), an Adverse Drug Event 
(ADE) is defined as any sign or symptom or disease which is unintended and harmful and happens 
for the normal dosage of the drug [1]. The two main approaches to discover ADEs are 
premarketing review and postmarketing surveillance. The premarketing review is carried out 
before the drug is released into the market to detect any potential adverse events. In 
premarketing review potential risks are identified and they are communicated to the prescribers. 
Unfortunately, the premarketing review process does not completely identify or address all 
possible adverse events due to the shortcoming of duration and size, thus mostly insufficient of 
detecting all adverse events caused by the drug [2]. Postmarketing surveillance is carried out by 
pharmacovigilance teams for reporting ADEs after the drug has been released into the market.  
High morbidity and mortality rates are associated with adverse drug events, and hence, 
pharmacovigilance serves a critical task in postmarketing surveillance [3], [4]. Existing traditional 
approach of reporting adverse events in postmarketing surveillance includes a centralized 
voluntary reporting system like U.S. FDA Adverse Event Reporting System (FAERS) [5], the Yellow 
Cards from the UK Medicines Agency (MHRA) [6], and VigiBase – the World Health Organization’s 
(WHO’s) ADE reporting system [7], [8]. Researchers have been working on finding and improving 
novel approaches for pharmacovigilance tasks besides the traditional approach by focusing on 
capturing real-time health data through healthcare content over Web 2.0 [9], [10]. Over the past 
decade many studies have used publicly available information sources: Web forums, chat rooms, 
blogs, social networking sites, news websites, personal webpages, and so on to detect ADEs [3].  
Recent advancements in pharmacovigilance tasks have shown that the usage of social 
media data as a good resource to obtain real-time signals for drug surveillance [8]–[13]. 
Researchers have shown a good potential for the detection of ADEs using social media much 
earlier than the traditional reporting systems [8], [14]. In this thesis, we address two key 
performance issues related to automated drug surveillance systems, the first is to improve the 
ADE signal detection by analyzing signals from multiple social media channels, and the second is 
usage of semantic similarity to evaluate ADE narratives detected by drug surveillance systems 
against official narratives, such as those from the FDA. 
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Most automated drug surveillance systems detecting adverse events from social media 
or Web 2.0 relied on single channels [3]. One exception is Adjeroh et al., which proposed that 
fusing heterogeneous signals from social media channels could generate good detection rate for 
adverse drug events [8]. Their results were quite promising as the signal fusion system they 
developed utilizing Twitter and search query log signals could detect drug alerts much earlier 
than the FDA. In this study we propose a new methodology to fuse signals from three different 
social media channels: Twitter, discussion forums and FDA Adverse Event Reporting System 
(FAERS) based on a causality model for ADE surveillance. Many studies have exhibited the 
usefulness of causality models in solving similar identification problems in economics [15]. We 
used graphical causal models to discover potentially hidden connections between data channels 
and use such associations to generate signals for adverse drug events.  
Also, we note that most of the work have not emphasized the issue of language usage. It 
is well-known that the language healthcare consumers use in expressing health issues on social 
media forums and microblogging websites like Twitter is often very casual and informal [16]. On 
the other hand, warning labels and notifications from official regulatory agencies (such as the 
FDA in the US) are formal documents and usually described in a language that is very carefully 
selected by biomedical experts. This raises a major concern as the words detected from social 
media channels by the surveillance systems do not exactly match with the contents of a typical 
FDA Black Box Warning (BBW) label or alert notification.  
For many pairs of terms, there is a potential to miss the semantic similarity between social 
media extracted ADE terms and terms from FDA notification when two sets of terms do not share 
exact text. More specifically, the problem is as follows: given a formal FDA ADE narrative: X= {x1, 
x2, … xn}, and an informal ADE narrative from social media Y= {y1, y2, … ym}, determine the 
semantic similarity between X and Y. The three major issues related to semantic similarity in 
automated drug surveillance are: 1) How to measure semantic similarity between social media 
narratives and official formal documents, 2) How to use semantic similarity to evaluate the 
accuracy of detected ADEs, and 3) How to use semantic similarity to improve ADE signal 
detection. This work focuses on the first two problems. In general, X and Y could represent any 
two documents with words from a given language. Thus, semantic similarity can have 
applications in other fields such as general healthcare, automobile industry, medical devices, 
ecommerce, etc. 
Previously, Yang et al. [11] attempted to address the problem of health consumers’ 
language over the Internet by generating adverse drug reaction (ADR) lexicons using Consumer 
Health Vocabulary (CHV) – developed by Zeng et al. [16]. However, this did not address the issue 
comprehensively, as there are over 200 biomedical vocabularies in just UMLS (Unified Medical 
Language System), which also includes CHV [17]. Here, we use UMLS-Similarity program 
developed by McInnes et al. [18], for computing semantic similarity. It incorporates well-known 
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semantic similarity and semantic relatedness measures. The prominent ones include path finding 
measures (such as Rada et al. [19], and Wu & Palmer [20]) as well as information content (IC) 
measures (such as Jiang and Conrath [21], and Sánchez et al. [22]). In prior work, Park et al. 
evaluated vocabularies from UMLS based on diabetes-related terms extracted from social media 
[23]. However, it confines itself to only one subset of the vast healthcare domain. In this work we 
focused on evaluating all the measures listed in UMLS-Similarity and vocabularies in UMLS to 
determine the best combination of measures and vocabulary in computing semantic similarity 
for evaluating adverse drug event narratives. 
 
1.2 Thesis Contributions 
 
The contributions of the thesis are summarized as follows: 
• A detailed study conducted on automated drug surveillance systems developed 
for detecting adverse drug events from social media. 
• Proposed a causality-based signal fusion scheme to generate adverse drug event 
signals from potentially hidden connections between social media channels. 
• Proposed methodology to use semantic similarity for evaluating the performance 
of automated drug surveillance systems against the gold standard FDA alerts. 
• The results reported in this thesis have crucial implications for various stakeholder 
groups, including regulatory agencies like FDA, health institutes, postmarketing 
monitoring teams, pharmaceutical companies and consumer advocacy groups. 
 
1.3 Thesis Outline 
 
Chapter 2 presents a brief background and prior work related to this thesis. It is organized 
in two parts. The first section discusses existing automated methods for adverse drug events 
surveillance using social media, and the characteristics of various social media channels based on 
the CRUFS methodology presented by Abbasi and Adjeroh [9]. The second section describes 
measures of semantic similarity developed over biomedical vocabularies, an overview of 
biomedical vocabularies in the UMLS Metathesaurus, and related work which demonstrated the 
use of semantic similarity in biomedical domain.  
In Chapter 3 we propose a novel methodology of signal fusion based on causality. Here, 
we introduce the dataset we used to generate signals followed by the methodology that explains 
the graphical causal model for signal fusion. We also describe the experiment setup to implement 
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our strategy, and finally a discussion on the results we obtained in comparison with prior work. 
In Chapter 4 we present our evaluation of semantic similarity measures and biomedical 
vocabularies for comparing the ADE narratives. We discuss various aspects of selecting and 
refining biomedical vocabularies to be used with similarity measures, and finally evaluating their 
combinations against human ratings to get the best vocabulary and measure configuration for 
our ADE surveillance problem domain. Lastly, concluding remarks and future directions are 
offered in Chapter 5. 
 
1.4 Publication Resulting in part from this Thesis 
 
H. I. Khaja, M. Abate, W. Zheng, A. Abbasi, and D. Adjeroh, “Evaluating Semantic Similarity 
for Adverse Drug Event Narratives,” in Proceedings - 2018 International Conference on Social 
Computing, Behavioral-Cultural Modeling & Prediction and Behavior Representation in Modeling 



















Background and Related Work 
 
The traditional systems for ADE reporting includes MedWatch from U.S. FDA Adverse Event 
Reporting System [5], the Yellow Cards from the UK Medicines Agency (MHRA) [6], and the 
VigiBase – the World Health Organization’s (WHO’s) ADE reporting system [7]. Each of these 
system work in a very similar fashion, that includes visiting their official website and reporting 
the ADE in detail by filling ADE reporting forms. The ADEs submitted to MedWatch becomes part 
of world’s largest ADE database, FDA’s Adverse Event Reporting System (FAERS). This database 
includes 6.2 million ADE records and around 400,000 records are added each year. However, only 
20,000 reports are submitted voluntarily by providers and patients each year. This varying extent 
of voluntary reporting is because of the lengthy, formal process which requires filling of an 
extensively detailed ADE reporting form which is time consuming and difficult [24]. Above all, 
FDA generally requires up to 44 months to detect an ADE associated with a drug [25], whereas, 
automated drug surveillance systems were able to successfully detect many ADEs at least 15 
months earlier (with some detected 2 to 3 years beforehand) [9]. 
 
2.1 Automated Adverse Drug Event Surveillance Systems 
 
Karimi et al. in their survey on postmarketing drug surveillance classified prior works into 
two main categories. The first class of methods uses social media resources to identify ADR 
mentions. The second delve into detection of adverse events using signal detection techniques, 
with the aim of reporting ADEs earlier than FDA [26].  
It has been observed that existing automated postmarketing drug surveillance systems 
have used various social media channels including forums like: DailyStrength [13], MedHelp [11], 
PatientsLikeMe [14] etc., search query logs from major search engines like Google, Bing, or 
Yahoo!, [14], [26], the advancement of Twitter as a superior micro-blogging website, many 
studies have demonstrated it as a good channel for monitoring drug signals [3], [8], [13], [14]. 
These channels exhibit different characteristics with respect to Credibility, Recency, Frequency, 
and Salience, an evaluation proposed by Abbasi and Adjeroh [9]. Social media channels such as 
Twitter and certain health forums have lower credibility as they are prone to spam. On the other 
hand, forums exhibit greater salience as they are capable of containing greater background and 
covering more context than a 140-character tweet, and far more relative to a query 
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encompassing a few search terms [9], despite having lower volume of content than Twitter and 
search queries. 
ADE signal detection from social media resources incorporates methodologies which are 
good enough to detect potential adverse events earlier than the gold standard FDA’s MedWatch. 
Precision, Recall and detection time has been the prominent evaluating factors for such ADE 
surveillance systems. Abbasi et al. [14] in their study discuss that most of the ADE signal detection 
approaches use “mention models” that build ADR occurrence frequency time-series at different 
temporal granularities (e.g., weekly, monthly, yearly), and apply temporal association rules or z-
score thresholds to the time series [14].  
Many works in automated ADE surveillance have relied on evaluating individual social 
media source channels: forum or microblogs or search query logs, rather a combination of these 
channels to evaluate adverse drug events detection. When applied to a large dataset, these 
methods have very low detection rates. In a prior work, Adjeroh et al. demonstrated correlation-
based peak labeling fusion scheme on Twitter and search query logs [8]. They showed that fusing 
these social media channels together could generate good detection rate for adverse events. 
Nevertheless, as is well known, correlation does not necessarily imply causation, neither is 
correlation necessary for causation [27]–[29]. We address this issue by applying causality models 
to fuse channel-wise time series data. Our causality problem using time series from drug-ADR 
references is different from traditional causality analysis: rather than the usual long-range time 
series [28], we focus on causality over local temporal windows. 
Another important aspect of this work is to determine the accuracy of suggested adverse 
drug events with respect to the reference ADE narrative for which we use semantic similarity. 
Additionally, semantic similarity can also be used to improve the strength of ADE signals from 
social media channels such as microblogs, chat rooms, web forums, social networks, and so on.   
 
2.2 Semantic Similarity Measures for Biomedical Vocabularies 
 
Semantic similarity is defined as a relatedness measure between two terms in a taxonomy 
having an IS-A relationship [19]. Semantic relatedness defines functional relationships, such as PART-
OF, TREATS, AFFECTED BY, and other functional relations in addition to IS-A relation. Semantic similarity 
measures are mainly classified into knowledge-based measures and distributional-based 
measures [30]. Knowledge-based semantic similarity measures are taxonomy-based measures. 
Typical examples include random walk, path finding, and information content (IC) measures [30]. 
Path finding based semantic similarity measures use the distance between two concepts in a 
taxonomy tree as the main objective of computing semantic similarity. A drawback of path 
7 
 
finding based measures is that they give equal weight to all relationships between concepts. This 
limitation is addressed by Information content (IC) based measures by allocating different 
weights to different relationships based on the information content of concepts [30]. Information 
content is a measure of concept specificity. Intrinsic IC measures compute information content 
(IC) of concepts from the taxonomic structure itself. The idea of intrinsic IC is based on the 
assumption that the taxonomic structure of vocabulary is organized in a comprehensive way, 
where concepts with many children and few parents have lower IC value than the concepts which 
are more specific or have less children. Random walk measures on the other hand simulate walks 
on a concept graph and define the relatedness on overall connectivity between concepts unlike 
the shortest path in path finding based and IC-based measures. 
Distributional-based measures deploy a domain corpus in addition to the taxonomic 
structure of the vocabulary [31]. A study by Pedersen et al. proposed a distributional-based 
measure called context vector measure for semantic relatedness and showed that this measure 
outperformed knowledge-based path finding measures [31]. Sánchez et al. showed that 
knowledge-based intrinsic IC measures outperformed distributional measures [32]. Garla and 
Brandt [30] observed that these studies have methodological differences preventing a direct 
comparison. However, they showed that for a wide range of vocabularies and benchmarks, 
intrinsic IC measures performed as well or better than distributional measures. In addition, they 
suggested the use of UMLS vocabularies for higher concordance with human judgments. Yet, no 
ADE specific evaluation has been done. Moreover, the performance of similarity measures 
heavily depends on vocabulary chosen. 
 
2.3 Biomedical Vocabularies in the UMLS Metathesaurus 
 
The UMLS, or Unified Medical Language System, is a set of files and software that brings 
together many health and biomedical vocabularies and standards to enable interoperability 
between computer systems [17]. The Metathesaurus is the biggest component of the UMLS. It is 
a large biomedical thesaurus that is organized by concept, or meaning, and it links similar names 
for the same concept from over 200 different source vocabularies. These vocabularies are 
electronic versions of various thesauri, classifications, code sets, and lists of controlled terms 
used in patient care, health services billing, public health statistics, indexing and cataloging 
biomedical literature, and/or basic, clinical, and health services research [33]. Some of the 
prominent source vocabularies in UMLS Metathesaurus includes:  ICD-10-CM (International 
Classification of Diseases, Tenth Revision, Clinical Modification), LOINC (Logical Observation 
Identifiers Names and Codes), MSH (Medical Subject Headings), RxNorm, and SNOMED CT 
(Systemized Nomenclature of Medicine Clinical Term). 
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In UMLS Metathesaurus, source vocabularies are represented by the acronym SAB 
(Source Abbreviation) and are organized based on concepts described by Concept Unique 
Identifier (CUI). CUI is the basic and most general representation of a concept or terminology 
wherein each CUI has its own definition/meaning, and the possible relations (REL) to other 
concepts are defined based on CUIs. Refer Table B.1 in Appendix B, for the list of all relationships 
defined in UMLS [33]. 
Several studies have earlier evaluated semantic similarity measures. These measures 
have been evaluated based on a specific standard rating coded by healthcare professionals as 
seen in Pedersen et al. [31] and Sánchez et al. [32], where pairs were coded by physicians and 
experts. In addition to this very few biomedical ontologies have been addressed in testing the 
semantic measures. Most efforts on this issue relied only on SNOMED CT or MSH considering 
these vocabularies as gold standard [30]–[32], while ignoring other biomedical vocabularies.  
Pesquita et al. [34] addressed some aspects of selection of semantic similarity measures, 
but the work is limited to Gene Ontologies and its specific applications. In our work, we consider 
the use of semantic similarity measures in general biomedical applications, especially where the 
terms are extracted from social media healthcare resources and other microblogging websites. 
For a social media generated signal, we have the language as a major concern and hence 
the testing on selection of semantic similarity measure and source vocabulary should be based 
on ratings obtained from general healthcare consumers, in addition to ratings from healthcare 
professionals. Thus, we used human ratings as the standard to compare the performance of each 
combination of measure and vocabulary configuration. The human ratings obtained for this 
evaluation consists of ratings from people who use social media as a primary source for health-
related information as well as ratings from people who are working in healthcare industry.  
Our methodology involves comparison of similarity values for every combination of 
semantic similarity measures and selected vocabulary configurations with human ratings as a 
benchmark to select the best combination as discussed in Chapter 4. Therefore, the objective of 
this work is to have a best combination of the vocabularies from UMLS Metathesaurus and the 
semantic similarity algorithms to compare the narratives in the reference document (E.g. FDA 
black box warnings), and the target narrative identified by the automated drug surveillance 
system using social media.  
In this thesis, we first demonstrate signal fusion using causality model to detect Adverse 
Drug Events and report the detection rate using this methodology. In addition to this, we evaluate 
the suggested ADE narrative against FDA’s black box warnings to measure the efficiency of the 
system using biomedical semantic similarity measures. We evaluate the efficiency in terms of 






Causality Based Signal Fusion for ADE Detection 
 
In this chapter, we propose a new methodology to fuse signals from three different social 
media user-generated content (UGC) channels: Twitter, Discussion Forums and FDA Adverse 
Event Reporting System (FAERS) based on a causality model for ADE surveillance. For causality 
modeling, we used graphical causal models to represent causal relations, and then used the 
Granger causality test to detect potential flags for ADE. This chapter is organized as follows: 
Section 3.1 introduces the dataset and signals we utilized for our work. Section 3.2 describes the 
causality model in detail including the Granger Causality tests, ADE signal detection and 
evaluation of detected ADE narratives against official FDA documents. Section 3.3 discusses the 
experimental setup for selecting possible candidates from the signals and filtering them to obtain 
the potential flag for ADEs. Finally, Section 3.4 provides a discussion of our experimental results 
and compares it with the correlation-based signal fusion methodology described in [8]. 
 
3.1 Dataset and Signals 
 
The methodology to generate signals has been adapted from Adjeroh et al. [8], where the 
authors described the signal generation process as simple drug-ADR reference model, based on 
a predefined list of keywords for human anatomy, drug reactions, and drug administration 
problems. That is, for a given data source, we consider joint references to a given drug (or its 
various aliases) and a keyword from each of the three keyword sets. We recorded the number of 
such references in terms of weeks from 2008 to 2014, and then formed a time series by 
normalizing these counts into empirical probabilities and z-scores. 
To identify potential ADR mentions, lexicons were developed for anatomy-related terms, 
reactions, and drug administration keywords. The lexicons, which were developed by research 
assistants with backgrounds in biology and medicine, were used to tag the tweets. For example, 
the statement “I’ve been through headaches since I started taking Actos.” would be tagged as 
“I’ve been through <ANATOMY><REACTION> since I started taking <DRUG>”. For word-sense 
disambiguation, we used the CMU part-of-speech tagger designed specifically for tweets [35], to 
help improve the likelihood that anatomy and side-effect tags were applied appropriately. 
For an adverse event E, given a time window ti ∈ T = {t1 ... tg}, where tg is the current time 
period of the analysis, and tg is less than the eventual event time period te. Let D(d) represent the 
10 
 
number of drug names associated with event E that appear in document d. Let C = {d1 ... dn} 
signify the set of documents occurring during ti within a given channel, where each D(dj) ≥ 1. 
Further, let A(dj), R(dj), and M(dj) represent the number of anatomy, reaction, and administration 
terms present in dj, respectively. The total raw score for time ti is then computed as:  
𝑠(𝑡𝑖) = ∑(𝐷(𝑑𝑗)  +  𝐴(𝑑𝑗)  +  𝑅(𝑑𝑗)  +  𝑀(𝑑𝑗))
𝑛
𝑗=1
                                                                              (1) 
Each s(ti) is converted to a z-score z(ti) = (s(ti) – μg)/σg , where μg and σg are the mean and 
standard deviation, respectively, across all ti in T plus the training period where s(ti) > 0. T can 
vary and depending on the resolution of the signals—such as daily, weekly, and monthly time 
models, as well as the value of the current window time period tg. 
We computed the signals for a total of 90 Drugs which had an FDA black box warning for 
ADEs between 2008 and 2015. Data from three user-generated content channels was collected: 
twitter, forums, and FDA Adverse Event Reporting System (FAERS). Approximately 12 million 
tweets containing drug-name keywords spanning 2008 to 2014 were gathered through Topsy’s 
API. Over 5 million postings from 10 popular health forums were obtained using web crawlers. 
The forums include: AskAPatient, CafePharma, DailyStrength, DrugBuyersGuide, Drugs.com, 
Drugs-Forum, eHealth, MedHelp, MedsChat, and PatientsLikeMe.  The postings spanned the time 
period 2008 onwards. In addition to the social media signals, we used FAERS data obtained for 
the selected drugs for the years 2008 to 2014 and processed them as signals using the above 
approach.  
 
3.2 Causality Based Signal Fusion 
 
For causality modeling, we used graphical causal models [15], [29], [36]–[38] to represent 
causal relations, and then used the Granger causality test [28], [39]–[42] to detect potential 
causal relations. Causality between two variables, say A and B is determined by checking their 
relationship with a third variable, say C, in particular their informational (in)dependence with C. 
For example, Graph (19) in Figure 3.1 (each rectangle contains equivalent structures. Figure 
adapted from [15]). An arrow indicates dependence between nodes. Thus, A and B are 
independent, while A and C have a dependence relationship. An overall network of causal 
relations in a large system can then be constructed by combining triples such as (A, B, C). Three 
key assumptions for graphical causal models are causal sufficiency, Markov condition, and 
stability [12]. In particular, the Markov condition states that the probability of a node can be 
written by conditioning on the node’s parent. Thus, given the network: A→B→C←D, the joint 
distribution can be written as: P (A, B, C, D) = P(A).P(D).P(B|A).P(C|B, D). Since C has two parents 
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B and D, both are involved in its representation. By computing all the possible joint probabilities 
for a given network triple, Kwon and Bessler [15] identified 11 possible classes of observationally 
equivalent causal structures for a given network triple. Figure 3.1 shows these classes for 
variables A, B and C. Each block denotes an equivalent class. For example, from Bayes theorem, 
we see that for Graph (12) (A→C→B), P (A, B, C) = P(A).P(C|A).P(B/C) = P(A). 
([P(A|C).P(C)]/P(A)).P(B|C) = P(A|C).P(C).P(B|C). Similarly, for Graph (13) (A←C→B), P (A, B, C) = 
P(C).P(A|C).P(B|C). Their joint probabilities are same; thus the two graphs are equivalent.  
 
 
Figure 3.1: Equivalent classes in graphical causal model. (From [15]) 
 
3.2.1 Granger Causality Test 
 
Engle and Granger [28] developed a method to check whether a given time series, say X(t) 
is caused by another time series, say Y(t), even when X and Y are not correlated. Here, Y(t) is said 
to be caused by X(t) if a series of t-tests and F-tests on lagged values of X and of Y, show that the 
statistically significant information about future values of Y are provided by the X values (see 
Figure 3.2). Basically, Y(t) causes X(t) if the future values of X(t) can be predicted more accurately 
using the lagged values of both Y(t) and X(t) than using only lagged values of X(t). In this work, 
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we model dependence based on Granger-causality. That is, A Granger-causes B (A→B) implies 
that B depends on A. 
 
  
Figure 3.2: Causality between two time-series variables (X and Y). 
 
3.2.2 Causality Based ADE Detection 
 
From Figure 3.1, we observe three interesting classes in Graph (7) (C→A←B), Graph (11) 
(A→C←B), and Graph (15) (A→B←C) (see Figure 3.3). These structures are unique -- they contain 
unconnected colliders or v-structures. Their joint probabilities cannot be factored into other 
representations [15]. These three classes identify causation among the given set of variables.  
 
 
Figure 3.3: Causal v-structures. 
 
Our problem is thus to search over the space of the causal directed acyclic graphs to 
identify these causal v-structures for our problem of ADRs. By specifying how the variables A, B, 
and C relate to our channels Forums, FAERS and Twitter, we convert our problem of signal 
detection to that of finding causal v-structures. Here, the nodes (variables) will correspond to 
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Forums, FAERS and Twitter, signals for each drug. We propose the following steps: (1) Map A, B, 
and C (network node triples) appropriately to our channels for each drug; (2) Identify pairwise 
dependencies (cointegration or causation) between variables using the Granger model based on 
a defined threshold for F-value (𝜏𝑓) and p-value (𝜏𝑝) for the F-tests; (3) Analyze results to 
determine causal v-structures. Each local region where a causal v-structure is detected becomes 
a candidate for an ADE. For each drug, we compute the candidates for the three v-structures. 
The potential flags are identified as the candidates occurring in at least one v-structure. 
For a given drug, the month with the highest number of flags denotes the detection of 
ADE as alert signal. The time specified by the alert signal will be considered as the detection time 
for ADE. We search the anatomy and reaction terms based on the detection time of the flag 
across all the three channels: Twitter, Forums and FAERS, and accumulate unique terms for both 
anatomy and reaction categories. We then match the obtained anatomy and reaction terms for 
the ADE against the anatomy and reaction terms given in FDA’s black box warning for the drug 
to evaluate precision and recall of the detected ADE terms. For computing precision and recall, 
we apply semantic similarity algorithms from the biomedical domain (discussed in chapter 4). 
 
3.3 Experiment Setup 
 
We obtained signals as described in Section 3.1 for a total of 335 weeks ranging from 
2007-12-30 to 2014-05-25 from three channels: Forums, FAERS, and Twitter for the list of 90 
drugs shown in Table A.1 in Appendix A. Of the 90 drugs there were 16 drugs which had multiple 
black box warnings on different dates and hence we analyzed them for each of the dates.  
For each drug, we compute the Granger causality across the permutation of pairs formed 
by the 3 channels using the grangercausalitytests program from statsmodels package in Python 
[43]. We specify the input parameter maximum lag as 3 and we design our Granger test for 
multiple window sizes (∆ = 8, 10, 12, 14, and 16 weeks). Graphically, our Granger model for 
testing causality between any two social media channels (say Forums(A) and Twitter(C)) can be 
depicted in Figure 3.4. Our causality testing for ADE surveillance is different from traditional 
causality analysis which usually focuses on long-range time series [28]. The figure explains that 
we test Granger causality over local temporal windows defined by the window size ∆. The whole 





Figure 3.4: Implementation of Granger causality tests over local temporal windows. 
 
3.3.1 Selecting Candidates for V-Structures 
 
We now analyze the Granger test results for the pairs of channels by forming the v-
structures for each window size separately. We defined our threshold for Granger results: 𝜏𝑓 as 
2.5 and 𝜏𝑝  as 0.15 a slightly moderate one to get more combination of flags. The set of candidate 
windows in v-structure (say A→C←B) are added from both Granger tests, A→C and B→C. For 
each window having any lag satisfying thresholds (𝜏𝑓 , 𝜏𝑝) in Granger test A→C, we select the 
corresponding nearest window from B→C which satisfies (𝜏𝑓 , 𝜏𝑝), as candidates in A→C←B. 
Likewise,  for each window having any lag satisfying thresholds (𝜏𝑓 , 𝜏𝑝) in Granger test B→C, we 
select the corresponding nearest window from A→C satisfying (𝜏𝑓 , 𝜏𝑝),  (see Figure 3.5).   
 
 
Figure 3.5: Forming candidates in causal v-structure (A→C←B). 
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To automate this process, we developed the procedure for candidate selection as shown 
in Figure 3.6 for choosing the candidate set of v-structures. 
Procedure for Selecting Candidates in V-Structures 
Algorithm FormStructure(A→C, B→C): 
1: Consider v-structure A→C←B (say A represents Forum, B represents FAERS, and C 
represents Twitter) and ∆ be the window size (for overlapping windows ∆ =1). 
2: Scan the results of A → C satisfying thresholds to get candidates, A_candidates 
3: D = SelectCandidates(A_candidates, B→C) 
4: Scan the results of B → C satisfying thresholds to get candidates, B_candidates 
5: D1 = SelectCandidates(B_candidates, A→C) 
6: Merge D & D1, store complete candidate set for A→C←B for window size ∆. 
 
Algorithm SelectCandidates(A→C, B→C): 
1: Initialize set D. 
2: for each row A_ID in A_candidates:  
// to find corresponding row in B → C, A_corres  
3: set B_ID = A_ID 
4: for B_IDArray = [B_ID – 2∆, B_ID – ∆, B_ID, B_ID + ∆, B_ID + 2∆] 
5:  rowID=B_IDArray[2]  
6:  if rowID has a candidate: 
7:   A_corres = rowID  
8:   break 
9:  rowID1= B_IDArray[1], rowID2= B_IDArray[3]  
10:  if rowID1 or rowID2 has a candidate: 
11:   if rowID1 has a candidate, A_corres = rowID1 
12:    else A_corres = rowID2 
13:    break 
14:   rowID1= B_IDArray[0], rowID2= B_IDArray[4]  
15:   if rowID1 or rowID2 has a candidate: 
16:   if rowID1 has a candidate, A_corres = rowID1 
17:    else A_corres = rowID2 
18:    break 
19:   A_corres = B_ID  
// if none of the neighbors is found  
20:   end if 
21: end for 
22:  merge A_candidates and A_corres, add to D. 
23: end for 
24: return D 




Figure 3.7 shows the graphical representation of the candidate selection process for the 
v-structure A→C←B. As shown in figure we have n windows for Granger test results for A→C and 
B→C, here n varies on the number of weeks and also the window size ∆. For each window (say x) 
having any lag satisfying thresholds (𝜏𝑓 , 𝜏𝑝) in A→C we find the corresponding window in B→C 
such that any lag in the window y=x or its closest neighboring windows (y-2∆, y-∆, y+∆, y+2∆) 
satisfies the thresholds (𝜏𝑓 , 𝜏𝑝). The process is repeated for windows in B→C, and we form such 
(x,y) candidates from A→C and B→C for the v-structure A→C←B.  
 
Figure 3.7: Candidate selection for A→C←B. 
 
Using this procedure, we compute candidate sets for all the window sizes (∆ = 8, 10, 12, 
14, 16 weeks), for the v-structures: A→C←B, A→B←C, and B→A←C. 
 
3.3.2 Finding Potential Flags 
 
We now report the potential flags for each drug representing a potential ADE. One can 
clearly observe that the procedure used to select candidates for forming the v-structures as 
discussed in Section 3.3.1 is not strict, as any window having a single lag satisfying the threshold 
(𝜏𝑓 , 𝜏𝑝) is considered to be a candidate. Thus, there is a need to filter the candidates before 
processing them for finding potential flags. In theory, it is desired to have all lags satisfying the 
threshold for a selected candidate, but this would be too strict and could miss some candidates.  
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In practice, we made the filtering process flexible by varying threshold (𝜏𝑓 , 𝜏𝑝) and defining rules 
based on the number of lags satisfying a given threshold (𝜏𝑓 , 𝜏𝑝). Given a v-structure A→C←B, 
we define rules Rule(α, β) as follows: For a selected candidate in  A→C←B, at least α number of 
lags should satisfy (𝜏𝑓 , 𝜏𝑝) on Granger test A→C and at least β number of lags should satisfy 
(𝜏𝑓 , 𝜏𝑝) on Granger test B→C, and vice versa. We choose rules:  
1. Rule(1,1),  
2. Rule(2,1),  
3. Rule(2,2), and  
4. Rule(3,1). 
where each rule would indicate the number of lags that satisfies (𝜏𝑓 , 𝜏𝑝) for Granger  
tests of a candidate in v-structure.  
Figure 3.8 shows an example for Rule(2,1). Here the Rule(2,1) for v-structure A→C←B, 
would only select candidates satisfying thresholds for at least 2 lags on Granger test A→C and at 
least 1 lag on Granger test B→C, and at least 1 lag on A→C and at least 2 lags on B→C.  
 
 






Empirically we decided two thresholds:  
1. 𝜏𝑓=2.5 with 𝜏𝑝=0.15 for all the 4 lag rules, and  
2. 𝜏𝑓=3.0 with 𝜏𝑝=0.05 only for Rule(1,1) and Rule(2,1). 
 
With the above threshold and lag rule combination we have 6 separate settings to filter 
candidate sets from v-structures:  
1. 𝜏𝑓=2.5 with 𝜏𝑝=0.15 for Rule(1,1), 
2. 𝜏𝑓=2.5 with 𝜏𝑝=0.15 for Rule(2,2), 
3. 𝜏𝑓=2.5 with 𝜏𝑝=0.15 for Rule(2,1), 
4. 𝜏𝑓=2.5 with 𝜏𝑝=0.15 for Rule(3,1), 
5. 𝜏𝑓=3 with 𝜏𝑝=0.05 for Rule(1,1), and 
6. 𝜏𝑓=3 with 𝜏𝑝=0.05 for Rule(2,1). 
 
For each drug we set the target date as 3 months before FDA’s black box warning date. 
The evaluation of potential flags for each setting is based on the filtered candidate set for v-
structures, such that the selected candidate for a flag should be present in at least two v-
structures and at least one signal in it should end before the target date.  
 
 
Figure 3.9: Finding potential flags from v-structures. 
 
For a given flag if both the signals in it ends before the target date then we consider it as 
red flag otherwise it is considered to be a yellow flag. We follow the procedure shown in Figure 




Procedure for finding Flags from Candidate Set 
Algorithm FindFlags(A→C←B, A→B←C, B→A←C): 
1: Consider setting (τf, τp) as threshold with lag rule Rule(n1, n2) and ∆ as window size. 
Take the target, as 3 months before FDA’s black box warning date. Initialize list D1. 
2: d1=FilterCandidates(A→C←B, τf, τp, n1, n2, ∆) 
3: d2=FilterCandidates(A→B←C, τf, τp, n1, n2, ∆)  
4: d3=FilterCandidates(B→A←C, τf, τp, n1, n2, ∆) 
5: s=MultipleOccurrence(d1, d2, d3) 
6: flags=SearchFlags(d1, d2, d3, s) 
7: <red_flags, yellow_flags> = RedYellow(flags, target) 
 
Algorithm FilterCandidates(X, τf, τp, n1, n2, ∆): 
1: Let A_ID, A_f1, A_p1, A_f2, A_p2, A_f3, A_p3 denote attributes for left-hand side of X. Let  
B_ID, B_f1, B_p1, B_f2, B_p2, B_f3, B_p3 denote attributes for right-hand side of X. 
2: Initialize D as empty dataframe. 
3: for candidate rows, C in X: 
4:  Initialize count1 = 0, count2 = 0. 
5: for i=1 to 3: 
6:   if A_fi >= τf and A_pi <= τp, increment count1, end if 
7:   if B_fi >= τf and B_pi <= τp, increment count2, end if 
8:  end for  
9:  if (count1 >=n1 and count2 >=n2) or (count1 >=n2 and count2 >=n1) add C to 
dataframe D, end if  
// D is filtered candidate set for v-structure X.  
10: end for 
11: return D. 
 
Algorithm MultipleOccurrence(d1, d2, d3): 
1: Initialize s as empty set  
// Finding potential flags.  
2: for dataframe, X in [d1, d2, d3]: 
3: initialize s1 as empty set  
4:  for candidate row, C in X:  
              // to add unique signals from the v-structure X 
5:  if A_ID is not in s1, append A_ID to s1, end if 
6:  if B_ID is not in s1, append B_ID to s1, end if 
7: end for 
8: append s1 to s. 
9: end for 
10: for j in s: 
11: if count(j) < 2, remove j from s, end if  
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              // candidates from multiple v-structures 
12: end for 
13: return s 
 
Algorithm SearchFlags(d1, d2, d3, s): 
1: Initialize K as empty dataframe. 
2: for each dataframe X, in [d1, d2, d3]: 
3: for candidate row, C in X: 
4:  if A_ID in s, append C to K, end if 
5:   if B_ID in s and A_ID not in s, append C to K, end if 
6: end for 
7: end for 
8: return K 
 
Algorithm RedYellow(flags, target): 
1: for each row, C in flags: 
2: if A_endDate < target and B_endDate < target, append C to red_flags. 
3: else if A_endDate < target or B_endDate < target, append C to yellow_flags. 
4: end if 
5: end for 
6: return <red_flags, yellow_flags> 
Figure 3.10: Algorithm for finding potential flags. 
 
Following the above algorithm, we computed red and yellow flags for the combinations 
of window sizes 10, 12, 14 and 16 weeks with the 6 rule settings defined above.  
 
3.3.3 Evaluating ADE Narratives 
 
Now that we obtained potential flags for all drugs using different settings and window 
configurations, we compute the month which has the highest number of potential red flags to be 
considered as the time for the alert signal for the drug. We also specify that in the absence of red 
flags, we consider the month which has the highest number of yellow flags as the alert signal. 





Figure 3.11: Methodology for causality-based signal fusion. 
 
Based on the alert signal month for each drug, we extract anatomy and reaction terms 
from all the 3 channels: Twitter, Forums and FAERS. The extracted anatomy and reaction terms 
are again processed to remove redundancy. Finally, we use Semantic Similarity measure sanchez 
with CHV-SNOMEDCT vocabulary configuration (refer Chapter 4) for evaluating our social media-
based ADE narratives against the official FDA documents. The performance is evaluated in terms 
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3.4 Experiment Results and Discussion 
 
3.4.1 Experiment Results 
 
As mentioned in the methodology section, we evaluated our approach using overlapping 
as well as non-overlapping window configurations for the time series data of the 90 drugs having 
a total of 107 FDA black box warnings. Table 3.1 and Table 3.2 represent a detailed result for 
detecting red and yellow flags for the complete dataset. 
 
Table 3.1: Detection using non-overlapping windows. 
Setting Total BBW 
Detected 
Detected as Red Detected as Yellow  
Maximum 
Flags for a Drug (𝝉𝒇, 𝝉𝒑) Rule 
(2.5, 0.15) (1, 1) 65 55 10 96 
(2.5, 0.15) (2, 1) 54 47 7 41 
(2.5, 0.15) (2, 2) 20 18 2 8 
(2.5, 0.15) (3, 1) 23 19 4 12 
(3.0, 0.05) (1, 1) 37 31 6 15 
(3.0, 0.05) (2, 1) 15 12 3 5 
 
Table 3.2: Detection using overlapping windows. 
Setting Total BBW 
Detected 
Detected as Red Detected as Yellow  
Maximum Flags 
for a Drug (𝝉𝒇, 𝝉𝒑) Rule 
(2.5, 0.15) (1, 1) 62 62 0 661 
(2.5, 0.15) (2, 1) 52 52 0 203 
(2.5, 0.15) (2, 2) 20 20 0 17 
(2.5, 0.15) (3, 1) 32 32 0 36 
(3.0, 0.05) (1, 1) 46 45 1 60 
(3.0, 0.05) (2, 1) 14 14 0 24 
 
For each configuration we computed the month which has the highest number of 
potential red flags of all the settings as alert signal for the drug. We also specify that in the 
absence of red flags, we consider the month which has the highest number of yellow flags as the 
alert signal. Thus, for each drug we obtain alert signal. We evaluate the performance of the 
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system in terms of Precision and Recall using the semantic similarity techniques. We evaluated 
our results for the drugs dataset discussed in Section 3.1. Table 3.3 shows these results 
summarized in terms of mean and median statistics over all the drugs for both overlapping and 
non-overlapping window configurations. Here we present the performance factors in terms of 
detection rate: the proportion of drugs identified as having a potential Adverse Drug Event. We 
also evaluate the suggested ADE narrative against the gold standard FDA black box warnings by 
computing the precision and recall for anatomy and reaction terms.  
 







Precision Recall Precision Recall 
Overlapping 0.62 
Mean 0.1883 0.5637 0.1778 0.5339 




Mean 0.1972 0.4524 0.1755 0.4649 
Median 0.1434 0.3765 0.1429 0.5500 
 
Timeliness or detection time is another perspective to evaluate an automated drug 
surveillance system. Detection rate tells us whether the considered approach is able to detect 
the adverse drug event or not, however one would also like to see how early the adverse drug 
events gets detected; so that it helps the concerned authorities like FDA to respond. Thus, we 
computed the detection time for each black box warning in terms of number of months prior to 
the FDA. Figure 3.12 shows the list of drugs detected with their earliest detection time prior to 





Figure 3.12: Detection time for drugs. 
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3.4.2 Comparison with Prior Work 
 
We have also compared our results against the correlation-based peak labeling fusion 
scheme for search engine query log terms and Twitter data used by Adjeroh et al. [8]. One key 
observation here is that Adjeroh et al. [8] used the dataset which had only 46 drugs experimented 
for FDA alerts. On the other hand, the drug dataset for this work is based on FDA blackbox 
warnings (BBWs) for a total of 90 different drugs. Furthermore, 16 drugs had more than one black 
box warning (the drug Aceon, had three black box warnings) making it a total of 107, which is 
more than double the size of dataset used in [8]. Thus, a direct comparison of all the performance 
factors cannot be done; however, the detection rate and the timeliness of detection provide a 
fair measure to compare how well the ADEs have been detected. Figure 3.13 and Table 3.4 show 
the comparison in terms of detection rate. (first 5 rows are described in [8]).  
 
Table 3.4: Comparing detection rate for fusion techniques. 
Fusion Technique Detection Rate 
fuse([Q, T], [52,104]) 0.6522 
fuse([Q, T], [n,52,104]) 0.5435 
fuse[Q, T], [n]) 0.3478 
fuse([Q], [n]) 0.4783 
fuse([T], [n]) 0.3261 
Causality-based (overlapping) 0.6222 






Figure 3.13: Detection rate comparison. 
 
The detection rate for both overlapping and non-overlapping configurations performed 
well better than 4 of the fusion techniques proposed by Adjeroh et al.  [8]. Also, we achieved a 
detection rate of 68 percent when we take into account the total detections from both 
overlapping as well as non-overlapping configurations which is more than the highest detection 
rate: 65 percent described in [8].  
We represent the timeliness in terms of maximum, mean and median statistic of 
detection time before FDA action for overlapping as well as non-overlapping window 
configurations; and then compare against the prior work [8] (see Table 3.5).  
 
Table 3.5: Timeliness comparison. 
Fusion Technique 
Detection time before FDA action (in months) 
Mean Median Maximum 
Causality-based (overlapping) 19.75 14.99 55.07 
Causality-based (non-overlapping) 19.46 14.00 56.02 
fuse([Q, T], [52,104]) [8] 23.58 23.5 36 
 
For both the causality-based window configurations we get almost the same result in 




















fuse([Q, T], [52,104]) fuse([Q, T], [n,52,104]) fuse[Q, T], [n])
fuse([Q], [n]) fuse([T], [n]) Causality - Overlapping
Causality - Non-Overlapping Causality-Combined
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detection time in comparison with prior work. However, prior work’s detection time for mean 
statistic was slightly better than our results, whereas the median statistic shows more difference 
in the timeliness of causality-based fusion techniques against the correlation-based fusion 
scheme described in [8]. 
As mentioned earlier, we used three different user-generated content (UGC) channels in 
this study for 107 blackbox FDA warnings. On the other hand, prior work used only Twitter and 
search query logs for the 46 FDA alerts drug dataset [8]. Thus, considering the dataset and the 
social media channels being used, our comparative analysis tells us that, the causality-based 




Clearly, we can see that Non-overlapping window configuration has slightly better 
detection rate when compared to overlapping window configuration (see Table 3.3). This could 
be due to the fact that the non-overlapping window covers a greater range of weeks for 
candidates in a v-structure allowing it to get a longer cross channel detection, thus having more 
potential candidates for drug signals. On the other hand, the overlapping window has a focused 
and shorter range of weeks for a given flag. This observation also answers the point that 
overlapping configuration has relatively greater precision and recall values than non-overlapping 
configuration, as the focused signals are the ones that have a high signal strength for a flag.  
From Table 3.2, it is evident that no yellow flags are detected for overlapping 
configuration except for the setting: (𝜏𝑓 = 3.0, 𝜏𝑝 = 0.05) with Rule(1,1), essentially forming the 
flags for shorter range and having more red flags than non-overlapping window configuration. 
Additionally, the maximum number of flags detected for any drug is far more than non-
overlapping window configuration for all settings. This observation could indicate that 
overlapping configuration is better capable of capturing more number of closer hidden 
connections between channels, but one needs to be cautious with the false alarms. A false alarm 
is defined as the potential flag representing an ADE falsely, i.e. an alert signal which does not 
correspond to the FDA action for a drug. Differentiating false alarms and improving the social 
media alert signal for the drugs could be an interesting future aspect to the study. 
In this work, we propose causality-based methodology to identify ADEs from the 
associations between social media UGC channels. Identifying the false alarms and detecting ADEs 







Evaluating Semantic Similarity for ADE Narratives 
 
In this chapter, we discuss a new approach to evaluate semantic similarity measures in 
biomedical domain for comparing ADE narratives. Our objective is to evaluate all the possible 
similarity measurement algorithms (SMAs) listed in UMLS-Similarity program along with the 
vocabulary configurations (VCs) from UMLS Metathesaurus database to determine the best 
combination of measures and respective vocabulary configurations in computing semantic 
similarity in the domain of adverse drug event surveillance. This chapter is organized as follows: 
Section 4.1 introduces the materials and methods focusing on the dataset we used and the 
methodology involved in this work. Section 4.2 describes the experiment and results in detail 
including the experimental setup, results computed in each phase, and finally results showing 
evaluation of ADE narratives. The last Section 4.3 presents a brief discussion on our methodology 
in the light of the results we obtained.  
 
4.1 Materials and Methods 
 
Our methodology follows the procedure: 1) Identify the best vocabulary configurations 
(VCs) to use, 2) Determine the best combination of VCs and similarity measurement algorithms 
(SMAs) via joint optimization, and 3) Perform semantic similarity measurement using VC and SMA 




Problem Domain Terms: In order to evaluate vocabulary configurations and similarity 
measures, we used anatomy and reaction terms extracted from social media channels for the 90 
drugs described in Chapter 3. The dataset was formed after the extracted terms were processed 
for removing redundancy. The dataset had 105 initial anatomy terms and 202 initial reaction 
terms (referred as clusters), which was expanded with words with similar meanings, resulting in 
a new list with 178 anatomy terms, and 417 reaction terms. Refer Appendix B for the list of 
problem domain terms and clusters. 
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Human Ratings: Language is a major concern in evaluating the signals generated from 
social media, hence, the testing on SMAs and VCs should be based on the ratings obtained from 
general healthcare consumers along with healthcare professionals. Thus, we used human ratings 
as the standard to compare the performance of each combination of SMA and VC. Initially, we 
had 178 anatomy terms and 417 reaction terms, and forming pairs with all these terms would 
lead to over 100,000 pairs and that would have been impossible for the respondents to rate the 
similarity. Thus, we randomly selected 30 anatomy terms forming a set of 435 [(30*29)/2] 
anatomy pairs and 40 reaction pairs forming a set of 780 [(40*39)/2] reaction pairs. Further, to 
rate these 1215 pairs we contacted 6 computer science graduate researchers having appreciable 
knowledge of biomedical vocabulary usage over social media. Finally, based on their ratings a 
template with a set of 100 pairs was designed comprising 50 anatomy pairs and 50 reaction pairs. 
This template had rating options 0, 0.25, 0.5, 0.75 and 1 indicating levels from non-similar to very 
similar. We obtained 130 user ratings across the United States. This consists of 54 individuals 
coming from 5 different universities with health sciences and engineering background, and 76 
from Amazon Mechanical Turk users having at least US Bachelor’s degree. Further, we selected 
117 ratings by excluding the outliers that had a negative correlation with the mean. We also 
analyzed the inter-rater agreement in terms of average correlation between raters. We filtered 
the ratings to achieve the benchmark of 80% average correlation and this resulted in a total of 
107 ratings. 
FDA BBW:  To evaluate our work, we used FDA black box warning (BBW) labels as gold 
standard references and extracted ADE terms from the labels. We used FDA BBW data from 
January 2008 to April 2015 (http://www.fda.gov/safety/medwatch/safetyinformation/). This 
included 107 BBWs, on 90 drugs over the seven-year period.  
 
4.1.2 Selection of Vocabulary Configurations (VCs) 
 
Since the biomedical terms are found in multiple vocabularies it becomes a challenging 
question to decide which vocabulary to be used. The harder part is to find how good a given 
vocabulary is, in terms of covering all terms in a given problem domain. 
Initial Selection:  As stated earlier, UMLS has a huge collection of biomedical vocabularies 
which serves as a good resource for our work. However, we cannot use all the vocabularies in 
UMLS-Similarity due to performance and computational issues (see [44] for example). For our 
domain-specific social media extracted ADE terms, we followed the discussions in Park et. al [23], 
and selected vocabularies represented by source abbreviation (SAB):  SNOMEDCT_US, CHV, MSH, 
LCH_NW, LNC, RXNORM, NCI_FDA, VANDF, and MTHSPL from UMLS [33]. We note that the work 
in [23] was based on terms extracted from social media using queries for terms related to 
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diabetes which is one of the most common groups of diseases and with a high degree of co-
morbidity. For a more comprehensive treatment, we have considered some additional 
vocabularies where the content is closely related to ADE terms; namely, FMA, MDR, UWDA, 
WHO, NCI_NICHD, NCI_CTCAE, NDFRT_FDASPL, ICD10CM, MTHHH, and GS. Thus, given our 
specific problem domain of analyzing adverse drug events over social media channels, we had a 
total of 19 vocabularies to start our study as shown in Table 4.1.  
 




US Edition of SNOMEDCT SNOMEDCT_US 
Consumer Health Vocabulary CHV 
Medical Subject Headings MSH 
Library of Congress Subject Headings, Northwestern University subset LCH_NW 
Logical Observation Identifiers Names and Codes (LOINC) LNC 
RxNorm Vocabulary RXNORM 
U.S. Food and Drug Administration NCI_FDA 
Veterans Health Administration National Drug File VANDF 
Metathesaurus FDA Structured Product Labels MTHSPL 
Foundational Model of Anatomy Ontology FMA 
Medical Dictionary for Regulatory Activities Terminology (MedDRA) MDR 
University of Washington Digital Anatomist UWDA 
WHO Adverse Reaction Terminology WHO 
National Institute of Child Health and Human Development NCI_NICHD 
Common Terminology Criteria for Adverse Events NCI_CTCAE 
National Drug File – FDASPL NDFRT_FDASPL 
International Classification of Diseases, 10th Edition, Clinical Modification ICD10CM 
Metathesaurus HCPCS Hierarchical Terms MTHHH 
Gold Standard Drug Database GS 
 
Refining the VC selection: Now that we have the vocabularies chosen from UMLS, our 
next task is to reduce the list to get the best possible vocabularies based on the concepts defined 
in each VC, and the coverage of problem domain terms.  To filter the vocabularies, we consider 
the following five features: 
1. Total CUI’s: Total number of concept unique identifiers (CUIs) listed for the vocabulary;  
2. Terms Detected: number of problem domain terms detected in the vocabulary; 
3. Concept coverage: number of concepts (CUI’s) listed for problem domain terms; 
4. Unique concepts: number of unique CUIs listed for each vocabulary; and 
5. Clusters Detected: number of clusters which had at least one term detected as CUI. 
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For our purpose, good vocabularies are expected to have higher values for each of these 
features. 
 
4.1.3 Similarity Measurement Algorithms (SMAs) 
 
 For automated evaluation of semantic similarity, the vocabulary is just one piece of the 
puzzle. Another key piece is the specific algorithm to be used to perform the similarity evaluation 
using the identified vocabulary. Thus, having narrowed down the vocabulary list as described 
above we now turn to the problem of selecting the SMAs. Interestingly, the match performance 
can also be influenced by the vocabulary used. Thus, the final choice of vocabulary cannot be 
made in isolation, but must consider the specific semantic similarity measurement algorithm 
being used. We used all the similarity measurement algorithms listed in UMLS-Similarity program 
except the vector measure which is meant to compute semantic relatedness (see Table 4.2). Each 
algorithm could have a range different for the similarity values, but for most, the range is from 0 
to 1. However, a value of -1 would indicate there is no similarity between the pair of terms based 
on the vocabulary configuration. A similarity value could be -1 for two reasons: either one or both 
terms in a pair is (are) not found in the given configuration, or there is no path in the configuration 
connecting the term pairs. 
 
Table 4.2: Similarity Measurement Algorithms in UMLS-Similarity.  
S. No. UMLS-Similarity Notation Type Reference 
1 lch path finding Leacock and Chodorow(1998) [45] 
2 wup path finding Wu and Palmer (1994) [20] 
3 zhong path finding Zhong et al. (2002) [46] 
4 path path finding path measure [18] 
5 upath path finding Undirected path [18] 
6 cdist path finding Rada et al. (1989) [19] 
7 nam path finding Nguyen and Al-Mubaid (2006) [47] 
8 res IC-based Resnik (1995) [48] 
9 lin IC-based Lin (1988) [49] 
10 jcn IC-based Jiang and Conrath (1997) [21] 
11 vector context vector Pedersen et al. (2007) [31] 
12 pks path finding Pekar and Staab (2002) [50] 
13 faith IC-based Pirro and Euzenat (2010) [51] 
14 cmatch feature-based Maedche and Staab (2001) [52] 
15 batet feature-based Batet et al. (2011) [53] 




4.1.4 Joint Selection of VC and SMA 
 
We computed similarity values for the problem domain terms using each combination of 
selected VCs and the SMAs. To select the best SMA and VC, we compared their results with those 
from human observers. Comparison of the computed similarity values against the human ratings 
is performed in two steps: (1) using Pearson correlation against the mean rating from human 
observers, and (2) using information retrieval measures.  
Correlation Analysis: For the mean representation of human ratings, we calculated the 
Pearson correlation coefficient against the corresponding computed similarity values. We used 
SciPy package in Python [54] to compute correlations. The syntax for correlation coefficient is 
given as: 
𝑟12  = [∑(𝑌𝑖1  −  𝑌1) ∗ (𝑌𝑖2  −  𝑌2)] / [∑(𝑌𝑖1  −  𝑌1)




                               (2) 
 
Correlation results helped us in reducing the number of combination of vocabulary 
configurations and similarity measurement algorithms. The combined results suggested 
favorable vocabularies as well as SMAs. We use these results for two key purposes: (1) Filtering 
the similarity measurement algorithms given all VCs; and (2) Analyzing the influence of SMAs on 
selection of vocabulary configurations.  
Information Retrieval Factors: To further evaluate which combination of measurement 
algorithms and vocabulary configurations produces computed ratings that best mirror the human 
ratings, we grouped the problem domain term pairs into three classes: similar pairs, unknown 
pairs, and non-similar pairs.  Let S(x,y) be the semantic similarity value between term pair (x, y), 
as returned by a given algorithm. We then used two thresholds 𝜏1 and 𝜏2 (𝜏1  ≥  𝜏2) to classify a 
word pair (𝑣1, 𝑣2) as follows: 
𝐶𝑙𝑎𝑠𝑠(𝑆(𝑣1, 𝑣2)) = {
𝑠𝑖𝑚𝑖𝑙𝑎𝑟,   𝑆(𝑣1, 𝑣2) >  𝜏1
𝑢𝑛𝑘𝑛𝑜𝑤𝑛,   𝜏1 ≥ 𝑆(𝑣1, 𝑣2) ≥  𝜏2
𝑛𝑜𝑡 𝑠𝑖𝑚𝑖𝑙𝑎𝑟,   𝑆(𝑣1, 𝑣2) <  𝜏2
                                                                     (3) 
We used traditional information retrieval measures, namely, Precision (Pr), Recall (Rc), 
and F-measure (Fm) to evaluate the performance of selected combinations of vocabulary 
configurations and similarity measurement algorithms across the three classes. The formula to 
compute each of these factors for a given class is given as: 
𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 (𝑃𝑟)  =  
𝑁𝐶  ∩  𝑁𝐻
𝑁𝐶  




𝑅𝑒𝑐𝑎𝑙𝑙 (𝑅𝑐)  =  
𝑁𝐶  ∩ 𝑁𝐻
𝑁𝐻
                                                                                                                          (5) 
where, 
NC = Number of computed pairs in a given class 
NH = Number of human pairs in a given class 
  
𝐹 − 𝑚𝑒𝑎𝑠𝑢𝑟𝑒 (𝐹𝑚)  =  
2 ∗ 𝑃𝑟 ∗  𝑅𝑐
Pr +  𝑅𝑐
                                                                                                      (6) 
For the final selection of best combination of vocabulary configuration and similarity 
measurement algorithm for the given problem domain terms, we combine the information from 
the correlation analysis, and from the information retrieval measures. 
 
4.2 Experiments and Results 
 
4.2.1 Filtering Vocabularies 
 
Using programs from the UMLS-Interface [18], we listed the Concept Unique Identifiers 
(CUIs) for vocabularies configured with combinations of relations (see Table 4.3). In Table 4.3, 
SAB refers to vocabularies and PAR (parent), CHD (child), RB (broader), and RN (narrower) are 
the relations defined in UMLS [17]. We observed that most vocabularies contain only PAR, CHD 
relations. While some have RB or RN as a primary way of representing hierarchy as seen for 
Medical Subject Headings (MSH). Interestingly, some vocabularies have concepts but are not 
connected by any relations. Thus, we chose to use relation categories: PAR, CHD; RB, RN; 
Similarity relations; and all relations. Similarity relations include all relations except XR (Not 
related), Empty relations and DEL (Deleted concept). For the complete list of all relations defined 
in UMLS, refer Table B.1 in Appendix B. 
Using the UMLS-Interface package, we obtain all the concepts (CUIs) for the problem 
domain terms for each vocabulary configuration. Thus, we can evaluate the vocabularies based 
on various features discussed in Section 4.1.2. Figures 4.1 – 4.4 show some of the features used 
to filter the vocabularies. 
Combination with CHV: Based on the results obtained (see Figure 4.1 – 4.4), we observed 
that the top 5 vocabularies for anatomy category are SNOMEDCT_US, CHV, LNC, MSH, and FMA. 
The top 5 vocabularies for reaction category are SNOMEDCT_US, CHV, MDR, MSH, and LNC. 
However, in Table 4.3, we see that CHV has only 2 CUIs for all the various types of relations 
specified. Clearly, this doesn’t mean that CHV has only 2 concepts defined in it (see Figure 4.1). 
In fact, CHV has no relations defined between CUIs which restricts its use independently. On the 
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other hand, we see that there are other vocabularies where we have concepts obtained for 
different relation configurations like PAR/CHD, RB/RN, similar relations and all relations. 
Interestingly, it is noted that when we provide more number of relations, the UMLS-Similarity 
program raises an error and more relations would have a huge computational impact. Thus, we 
decided to include significant relations based on the number of concepts retrieved in Table 4.3 
as shown in Table 4.4. The sources listed in Table 4.4 were used in combination with CHV as it 
has more coverage of terms and improves results as seen in previous work [11], [23], [30]. 
 
Table 4.3: Number of concepts in UMLS vocabularies using the SAB/REL configurations. 
SAB/REL PAR, CHD RB, RN Similar Relationships All Relationships 
CHV 2 2 2 2 
FMA 97817 2 97830 97830 
GS 2 2 2 2 
ICD10CM 91673 2 101407 101407 
LCH_NW 2 2 14578 14578 
LNC 113526 24157 166393 166393 
MDR 23439 2 53175 53175 
MSH 28575 346054 366174 366174 
MTHHH 7142 2 7142 7142 
MTHSPL 2 2 50635 50635 
NCI_CTCAE 2 2 2 2 
NCI_FDA 2 2 2 2 
NCI_NICHD 2 2 2 2 
NDFRT_FDASPL 2 2 9137 9137 
RxNorm 2 173552 202077 202077 
SNOMEDCT_US 321004 43208 357226 357997 
UWDA 61087 61087 61087 61087 
VANDF 2 25072 31727 31727 
WHO 1737 3176 3178 3178 
 
Table 4.4: Relations used for selected source vocabularies. 










Figure 4.1: Percentage of terms detected. 
 
 















































Figure 4.3: Percentage of unique concepts(CUIs) obtained. 
 
 




















































4.2.2 Joint Selection of VC and SMA 
 
Correlation Analysis: If the significance level is ≤ 5% (i.e., P-value ≤ 0.05) and the 
corresponding correlation coefficient is positively high for any vocabulary configuration and 
similarity measurement algorithm, then we say that SMA or VC is favored. From Table 4.5, and 
Figures 4.5 and 4.6, we can see that for anatomy category the similarity measurement algorithms 
which frequently appear to be good are cmatch, jcn and sanchez with vocabulary configurations 
CHV-SNOMEDCT_US and CHV-LNC. 
For reaction category, we did not get significant p-value to favor any of the algorithms. 
However, it has been observed that nam has very high correlation coefficient with vocabularies 
CHV-MDR and CHV-MSH, and undefined value for CHV-LNC. This behavior is because of the 
similarity values being -1.0 for most term pairs, resulting in less variability. Overall, the correlation 
analysis suggests that CHV-SNOMEDCT_US and CHV-MDR are the best VCs for working on 
reaction category terms (see Figure 4.6). Detailed results showing correlation coefficient and p-
value for each SMA and selected VC are given in Appendix B, refer Table B.4 and Table B.5 for 
anatomy and reaction categories respectively. 
 
    Table 4.5: Outcomes of Pearson correlation. 
Category SMA favored VC favored 
Anatomy cmatch, jcn, sanchez CHV-SNOMEDCT_US, CHV-LNC 





Figure 4.5: Correlation of computed similarity with human ratings – Anatomy pairs. 
 
 



















































CHV-LNC CHV-MDR CHV-MSH CHV-SNOMEDCT_US
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Information Retrieval Factors: For the median of human ratings, we chose thresholds 𝜏1 
as 0.75 and 𝜏2 as 0.3 to classify them into similar pairs, unknown pairs, and non-similar pairs. 
Similar to human ratings, for the SMA-VC obtained similarity values we chose 𝜏1 ranging from 0.5 
to 0.95 and 𝜏2 ranging from 0.05 to 0.45 with a step size of 0.05. We selected the top 5 SMA-VCs 
based on F-measure against human rating statistic. For anatomy terms (Table 4.6), we found that 
the algorithms jcn, faith, lin, cmatch and sanchez with CHV-SNOMEDCT_US vocabulary are having 
high F-measure values with respect to human ratings. For reaction category (Table 4.7), the 
algorithms wup, lin, pks, cmatch with CHV-SNOMEDCT_US vocabulary configuration, and res with 
CHV-MDR vocabulary configuration performed well. Interestingly, we observe that sanchez has 
good F-measure for both CHV-SNOMEDCT_US and CHV-MDR. 
Table 4.6 and 4.7 shows results only for similar pairs class. Detailed results for each class 
including similar pairs, non-similar pairs, unknown pairs are described in Table B.6 and Table B.7 
given in Appendix B for anatomy and reaction categories respectively. 
 
Table 4.6: Top 5 Similarity Algorithm/Vocabulary Configurations (Similar Pairs – Anatomy). 
Measure τ1 τ2 τdiff Configuration Pr Rc Fm 
jcn  0.8  0.5  0.3  CHV-SNOMEDCT_US  0.89  0.62  0.73  
faith  0.7  0.5  0.2  CHV-SNOMEDCT_US  0.89  0.62  0.73  
lin  0.8  0.45  0.35  CHV-SNOMEDCT_US  0.89  0.62  0.73  
cmatch  0.5  0.45  0.05  CHV-SNOMEDCT_US  0.73  0.62  0.67  
sanchez  0.8  0.5  0.3  CHV-SNOMEDCT_US  0.73  0.62  0.67  
 
Table 4.7: Top 5 Similarity Algorithm/Vocabulary Configurations (Similar Pairs – Reaction). 
Measure τ1 τ2 τdiff Configuration Pr Rc Fm 
pks  0.55  0.35  0.2  CHV-SNOMEDCT_US  1  0.3  0.46  
res  0.8  0.3  0.5  CHV-MDR  1  0.3  0.46  
sanchez  0.5  0.4  0.1  CHV-MDR  1  0.3  0.46  
wup  0.75  0.3  0.45  CHV-SNOMEDCT_US  1  0.3  0.46  
sanchez  0.85  0.3  0.55  CHV-SNOMEDCT_US  0.75  0.3  0.43 
 
4.2.3 Application to Evaluating ADE Surveillance Systems 
 
Considering both the information retrieval factors the correlation analysis, our results 
suggest the following: for anatomy term pairs, we should use jcn, cmatch, or sanchez similarity 
measurement algorithm with CHV-SNOMEDCT_US vocabulary configuration. For reaction term 
pairs, we should use sanchez, res, or wup similarity measurement algorithm, with CHV-
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SNOMEDCT_US or CHV-MDR vocabulary configuration. A key observation is the need for a 
combination of vocabularies (typically, CHV with some others), rather than one single vocabulary 
as has been used in prior work, such as [8]. Prior work also did not consider the impact of the 
similarity measurement algorithm on the results. We evaluated suggested ADE narratives from 
social media based on the method described in Chapter 3 for non-overlapping windows using the 
BBW data discussed in Section 4.1.1. We considered four cases (see Table 4.8): exact match i.e., 
not using semantic similarity; and the other 3 cases with similarity measure algorithm sanchez 
along with vocabulary configurations CHV, SNOMEDCT_US and combination of CHV-
SNOMEDCT_US. Exact match is a string matching technique as used in Adjeroh et al. [8] where 
the authors used this methodology to compare the ADE narratives by expanding terms having 
similar meanings. The obtained results indicate that using semantic similarity has significantly 
greater improvement, especially, our suggested approach using a vocabulary configuration 
combining CHV-SNOMEDCT_US outperformed others.  
 
Table 4.8: Evaluating social media ADE narratives for BBW data. 
Approach 
Anatomy Reaction 
Pr Rc Fm Pr Rc Fm 
exact match 0.048 0.176 0.076 0.022 0.140 0.038 
CHV 0.048 0.176 0.076 0.024 0.141 0.041 
SNOMEDCT_US 0.181 0.395 0.249 0.155 0.402 0.224 




In our implementation, we chose UMLS-Similarity as it is built on UMLS which provides 
access to multiple vocabularies unlike other alternatives which require configuring vocabularies 
individually. In addition to this advantage, it has been observed in prior studies that using UMLS 
vocabularies would generate good results having higher agreement with human judgements [11], 
[23], [30]. 
The human ratings we used had a good representation of doctors, health professionals, 
health science students, engineering graduates and general graduate students. We even 
collected responses from Amazon’s Mechanical Turk users having at least a US Bachelor’s Degree 
[55]. Overall we achieved an interrater agreement of 80% average correlation for over a hundred 
human observer ratings. As the participants were familiar with social media as a significant source 
of healthcare information and considering the interrater agreement, we believe our dataset best 
fits the testing. 
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We followed a-step-by-step approach testing all the vocabulary configurations and 
similarity measure algorithms exhaustively, to get the best suitable VC and SMA combination for 
the adverse drug event terms. Our results showed that the configuration of CHV-SNOMEDCT_US 
is the best for anatomy terms using the IC-based similarity measure algorithms sanchez and jcn. 
It is also observed that CHV-MDR and CHV-SNOMEDCT_US configurations work well for reaction 
category terms with sanchez similarity measure algorithm. However, our results also indicate 
that using biomedical ontologies and the similarity measures is not sufficient for reaction 
category terms. The major reason is that reaction terms are more general and are not as specific 
when compared to anatomy category terms. Thus, we believe that using general English 
vocabularies such as WordNet [56] along with UMLS would improve the semantic similarity for 
reaction category terms. 
Our findings also show that the vocabulary MedDRA -- Medical Dictionary for Regulatory 
Activities (abbreviated as MDR in UMLS) has a good representation of reaction category problem 
domain terms. This can be considered in the light of the fact that SIDER, a well-known dataset for 





















Conclusion and Future Work 
 
We study the problem of Adverse Drug Events and the postmarketing drug surveillance 
involved to detect such harmful events.  The study included examining prior works in adverse 
drug events (ADE) detection using social media as a prime resource. Primarily our objective was 
focused on fusing social media UGC channels for ADE detection, as the signal fusion technique 
had seen to be generating promising results in terms of early detection of ADE. During this study 
we introduced a novel approach of using graphical causal model for social media signal fusion. 
Using the proposed Causality-based technique, we were able to investigate ADE detection on 90 
drugs having a total of 107 FDA black box warnings. Further, we presented a methodology to 
evaluate precision and recall of detected ADE narratives against the gold standard FDA using 
semantic similarity algorithms published in biomedical domain. 
We experimented different similarity measure algorithms designed for biomedical 
ontologies. We showed that choosing a measure alone is not enough for computing semantic 
similarity for terms in a problem domain. Likewise, having known of a vocabulary which is related 
to a particular problem domain does not solve the problem of computing semantic similarity for 
the terms in that problem domain. We defined a way of choosing the vocabulary first, we also 
showed that combining a vocabulary with CHV improves the concept coverage and thereby 
covering more terms from the problem domain and later we experimented each configuration 
of vocabulary with different measures. The results shown in this work are based on the existing 
measures published in UMLS-Similarity program version 1.47 and the source vocabularies 
extracted from UMLS version 2017AA. For future releases of UMLS and the UMLS-Similarity 
program the methodology we developed can still be used to find the best measure and 
vocabulary configuration combination for a given problem domain terms.  
 Unlike most of the prior studies which focused only on ADE detection or some of them 
just representing the recall of detected ADE narrative, we evaluated the detected ADEs in terms 
of timeliness, recall and precision. Our results had a good detection rate, precision and recall 
considering the dataset we have used representing over 100 FDA black box warnings. In future 
we would like to further examine causality on fusing additional social media channels including 
search query logs. Identifying the false alarms and detecting ADEs for unknown FDA blackbox 
warnings could be some of the prospective studies. Another direction for future work could be 
to implement semantic similarity algorithms in capturing signals from social media channels. Also 
utilizing general English vocabularies like WordNet [56] in addition to UMLS could be one more 
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Causality Based Signal Fusion 
 
Table A.1: List of 90 drugs used in Causality Based Signal Fusion. 
ABLAVAR EXJADE AVELOX LETAIRIS RITUXAN 
FIORICET ONTAK PERFOROMIST COZAAR SEREVENT 
ACTIQ MULTAQ MULTIHANCE MAGNEVIST SIMPONI 
TEKTURNA RANEXA OMNISCAN CELLCEPT RAPAMUNE 
ALTACE DEPAKENE PROHANCE MYFORTIC OSMOPREP 
ARZERRA HALCION OPTIMARK VIRAMUNE VISICOL 
ATACAND ADVAIR EOVIST NIZORAL SUTENT 
AVANDAMET OCTAGAM HUMIRA ORTHO EVRA TASIGNA 
AVANDIA ZORTRESS PRINZIDE MITOXANTRONE HCL TASINGA 
IMURAN ELAPRASE HYZAAR NOVANTRONE INCIVEK 
REGRANEX RAPTIVA IDURSULFASE ZYPREXA ANDROGEL 
BROVANA TRUVADA INCLUSIG ORTHO NOVUM FARESTON 
SYMBICORT ENBREL INFED ACEON TYGACIL 
ZYBAN ESTRADERM SOPRANOX PROMACTA TYSABRI 
APLENZIN POTIGA SPORANOX PROPYLTHIOURACIL ULTRACET 
CIMZIA FACTIVE EPZICOM QUALAQUIN PROMETRIUM 
CLEOCIN FLOXIN TRIZIVIR REGLAN STAVZOR 
















Evaluation of Semantic Similarity for ADE Narratives 
 
Table B.1: Relationships defined in UMLS. 
REL (Relationship) Description 
AQ Allowed qualifier 
CHD has child relationship in a Metathesaurus source vocabulary 
DEL Deleted concept 
PAR has parent relationship in a Metathesaurus source vocabulary 
QB can be qualified by. 
RB has a broader relationship 
RL 
the relationship is similar or "alike". the two concepts are similar or 
"alike". In the current edition of the Metathesaurus, most relationships 
with this attribute are mappings provided by a source, named in SAB and 
SL; hence concepts linked by this relationship may be synonymous, i.e. 
self-referential: CUI1 = CUI2. In previous releases, some MeSH 
Supplementary Concept relationships were represented in this way. 
RN has a narrower relationship 
RO has relationship other than synonymous, narrower, or broader 
RQ related and possibly synonymous. 
RU Related, unspecified 
SIB has sibling relationship in a Metathesaurus source vocabulary. 
SY source asserted synonymy. 
XR Not related, no mapping 








Problem Domain Terms used in Evaluation of Semantic Similarity 
 
This appendix lists all the biomedical terms used in this research. It is organized as follows: 
1. Clusters - The problem domain terms for this research are represented in terms of 
clusters having one or more terms for each cluster. The clusters are organized into: 
a. Anatomy Clusters 
b. Reaction Clusters 
 
2. Terms – The multiple terms representing each cluster are expanded to get total terms 
in each category:  
a. Anatomy Terms 
b. Reaction Terms 
 
1.a Anatomy Clusters 
 




3. {anus, anal} 
4. {appendix} 
5. {arm, arms} 




10. {bone marrow} 
11. {bone, bones} 
12. {brain} 
13. {breast, breasts, boob, boobs} 
14. {buttocks, butt, ass} 
15. {canal} 
16. {cardiovascular, cardio} 
17. {cervex, cervical} 
18. {cheek, cheeks, cheekbones} 
19. {chest} 
20. {child, children, childrens, children's} 
21. {chin} 
22. {clavical} 




25. {ear, ears, earlobe, earlobes} 
26. {elbow, elbows} 
27. {erectile} 
28. {eye, eyes} 
29. {face} 
30. {female, females} 
31. {foot, feet} 
32. {forearm, forearms} 
33. {forehead} 
34. {gastric} 
35. {genital, genitals} 
36. {gland, glands} 
37. {hair} 
38. {hand, palm} 
39. {head} 
40. {heart, heartbeat} 
41. {heel} 
42. {hip, hips} 
43. {hive, hives} 
44. {immune system} 
45. {impair, impaired} 
46. {infant, infants} 
47. {intestinal, intestine, intestines} 
48. {joint, joints} 
49. {kidney} 
50. {knee, knees} 
51. {leg, legs} 
52. {ligament, ligaments} 
53. {lip, lips} 
54. {liver} 
55. {lobe, lobes} 
56. {lumbar} 
57. {lung, lungs} 
58. {lymph node, lymph nodes, lymph gland, lymph glands} 
59. {lymph} 
60. {macular} 
61. {male, males} 
62. {man, men} 
63. {mental} 
64. {mouth} 
65. {muscle, muscles, muscular} 




68. {nerve, nerves} 
69. {newborn, newborns} 
70. {nipple, nipples} 
71. {nose} 





77. {plasma cell, plasma cells} 
78. {pregnant, pregnancy} 
79. {pulmonary} 
80. {pulse} 
81. {rectum, rectal} 
82. {respiratory} 
83. {retina, retinal} 
84. {rheumatic} 
85. {shoulder, shoulders} 
86. {sinus} 
87. {skin} 





93. {testicle, testicular, testes} 




98. {tonsil, tonsils} 
99. {tooth, teeth} 
100. {urinary} 
101. {vagina, vaginal} 
102. {vein, venous, veins} 
103. {white blood cell, white blood cells} 
104. {women, woman} 









1.b Reaction Clusters 
 
We have 202 clusters in reaction category listed as follows: 
1. {abnormality, abnormalities, abnormal} 
2. {ache, aching, aches, ached} 
3. {acne} 
4. {acute} 
5. {addiction, addictive} 
6. {adverse} 
7. {aggression, aggressive} 
8. {agitate, agitated, agitates, agitation} 
9. {akathisia} 




14. {anorexia, anorexic} 
15. {anxiety, anxious} 








24. {bleed, bleeding, bleedings, bleeds, blood, bloody} 
25. {blind, blindness} 
26. {blister, blisters} 
27. {blur, blurred, blurry, blurs} 
28. {bradycardia} 
29. {breakdown} 
30. {breath, breathe, breathing} 
31. {burn, burning, burns, burned} 
32. {cancer, cancerous} 
33. {cause, causes, caused} 
34. {chill, chills} 
35. {chronic} 




40. {convulsion, convulsions} 
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41. {cramp, cramps, cramping} 
42. {crohns disease, crohn syndrome, regional enteritis} 
43. {crystalization, crystal, crystals} 
44. {damage, damaged, damages} 
45. {danger, dangers, dangerous, dangerously} 
46. {deaf, deafness} 
47. {death, dead, died} 
48. {decrease, decreasing, decreased} 
49. {depressed, depression} 
50. {destruction, destroy, destroys, destroyed} 







58. {dizziness, dizzy} 







66. {effect, effects} 
67. {epilepsy} 
68. {excess, excessive, overly} 
69. {exhaustion, exhausted, exhausting} 
70. {explode, exploding, explosive, explosion} 
71. {failure, failures} 
72. {faint, fainting} 
73. {fatigue, fatigued, fatiguing, fatigues} 
74. {fetal circulation} 
75. {fever, fevers} 
76. {flush, flushed, flushes, flushing} 
77. {fracture, fractures} 
78. {gas, gaseous, gassy, gastritis} 
79. {hallucinating, hallucinations} 
80. {headache, headaches} 
81. {heartburn} 
82. {hepatitis c, hcv} 
83. {hive, hives} 




86. {human immunodeficiency virus, hiv, acquired immunodeficiency syndrome, aids} 







94. {ill, illness} 
95. {impair, impaired, impairs, impairing} 
96. {impotence, impotent} 
97. {impulsive} 
98. {inability, unable} 
99. {increase, increased, increasing} 
100. {indigestion} 
101. {infect, infected, infection, infects, infections} 
102. {inflamation, inflamed, inflame} 
103. {injure, injury, injuries, injured} 
104. {insomnia} 
105. {interaction, interactions} 
106. {interval, intervals} 
107. {irreparable} 
108. {irreversible} 
109. {irritable, irritate, irritated, irritability, irritates} 




114. {leukoencephalopathy, leukodystrophy} 
115. {loss, losses} 
116. {lymphoma} 





122. {murmur, murmurs} 
123. {myopathy, myopathic} 
124. {nausea, nauseous} 
125. {nervousness} 
126. {neuropathy} 
127. {numb, numbness, numbing} 
128. {obstructive sleep apnea, osa} 
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140. {problem, problems} 
141. {progressive multifocal leukoencephalopathy, pml} 
142. {psychiatric, psychotic, psychosis, psycho} 
143. {pulmonary arterial hypertension, pah, pulmonary hypertension} 
144. {pulsate, pulsating} 
145. {rapid, rapidly} 
146. {rash, rashes} 
147. {react, reaction, reactions} 
148. {reduce, reducing, reduced, reduction, reductions} 
149. {regulatory, regulation, regulate} 
150. {rhythm, rhythms} 
151. {ringing} 
152. {runny} 
153. {rupture, ruptures, ruptured, rupturing} 
154. {sad, sadness} 
155. {sclerosis} 
156. {seizure, seizures, seizing} 
157. {sensation} 
158. {sensitivity, sensitive} 
159. {serious, seriousness, seriously} 
160. {serotonin syndrome, serotonin toxicity, serotonin sickness, serotonin poisoning} 
161. {severe, severely} 
162. {shakiness, shaky} 
163. {sharp} 
164. {short, shortness, shortening, shorter} 
165. {sleep, sleeping, sleepiness, slept} 
166. {sore, soreness} 
167. {spasm, spasms} 
168. {stroke, strokes} 
169. {stuffy, stuffiness, congest, congested, congestion} 
170. {sudden} 
171. {sugar, glycosylate, glycosylated, hemoglobin, hba1c} 
172. {suicidal, suicide} 
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173. {sweat, sweats, sweating} 
174. {swell, swelling, swollen, swells} 
175. {syncope} 
176. {tachycardia} 




181. {terrified, terrifying} 
182. {thrombosis, thromboembolism} 
183. {tingle, tingling} 
184. {tinnitus} 
185. {tired, tiredness, tire} 
186. {torsades de pointes, ventricular tachycardia} 
187. {toxicity} 
188. {trauma, traumatic} 
189. {tremor, tremors} 
190. {tumor, tumors, tumorous} 
191. {ulcer, ulcers, ulcerative} 
192. {unexplained} 
193. {upset, irritated, irritable, irritate, irritation, upsetting} 
194. {vaginitis} 
195. {vertigo} 
196. {virus, viral} 
197. {vomit, vomits, vomiting, vomited} 
198. {wart, warts} 
199. {watery} 
200. {weak, weaken, weakening, weakness, weaknesses} 
201. {weight} 



















2.a Anatomy Terms 
 
For the 105 anatomy clusters we have 178 anatomy terms as shown in Table B.2. 
 
Table B.2: Anatomy terms. 
abdomen achilles anus 
anal appendix arm 
arms artery arteries 
arterial back bladder 
blood bone marrow bone 
bones brain breast 
breasts boob boobs 
buttocks butt ass 
canal cardiovascular cardio 
cervex cervical cheek 
cheeks cheekbones chest 
child children childrens 
children's chin clavical 
cognitive cognition colon 
ear ears earlobe 
earlobes elbow elbows 
erectile eye eyes 
face female females 
foot feet forearm 
forearms forehead gastric 
genital genitals gland 
glands hair hand 
palm head heart 
heartbeat heel hip 
hips hive hives 
immune system impair impaired 
infant infants intestinal 
intestine intestines joint 
joints kidney knee 
knees leg legs 
ligament ligaments lip 
lips liver lobe 
lobes lumbar lung 
lungs lymph node lymph nodes 
lymph gland lymph glands lymph 
macular male males 
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man men mental 
mouth muscle muscles 
muscular nail nails 
neck nerve nerves 
newborn newborns nipple 
nipples nose ovarian 
ovary ovaries pancreas 
pectoral pelvis peptic 
plasma cell plasma cells pregnant 
pregnancy pulmonary pulse 
rectum rectal respiratory 
retina retinal rheumatic 
shoulder shoulders sinus 
skin spine spinal cord 
spleen sternum stomach 
tendon testicle testicular 
testes thigh thighs 
thoracic throat tongue 
tonsil tonsils tooth 
teeth urinary vagina 
vaginal vein venous 
veins white blood cell white blood cells 
women woman wrist 






















2.b Reaction Terms 
 
For the 202 reaction clusters we have 417 reaction terms as shown in Table B.3. 
 
Table B.3: Reaction terms. 
abnormality abnormalities abnormal 
ache aching aches 
ached acne acute 
addiction addictive adverse 
aggression aggressive agitate 
agitated agitates agitation 
akathisia allergic allergy 
allergen amnesia anemia 
angina anorexia anorexic 
anxiety anxious appendicitis 
appendectomy arrhythmia asthenia 
atrocious attack awful 
bad benign bleed 
bleeding bleedings bleeds 
blood bloody blind 
blindness blister blisters 
blur blurred blurry 
blurs bradycardia breakdown 
breath breathe breathing 
burn burning burns 
burned cancer cancerous 
cause causes caused 
chill chills chronic 
clot clots clotting 
colitis confusion constipation 
convulsion convulsions cramp 
cramps cramping crohns disease 
crohn syndrome regional enteritis crystalization 
crystal crystals damage 
damaged damages danger 
dangers dangerous dangerously 
deaf deafness death 
dead died decrease 
decreasing decreased depressed 
depression destruction destroy 
destroys destroyed diabetes 
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diabetic diarrhea difficult 
dire disorder diverticulitis 
diverticulosis dizziness dizzy 
drowsiness drowsy dysfunction 
dyskinesia dyspepsia dyspnea 
eczema edema effect 
effects epilepsy excess 
excessive overly exhaustion 
exhausted exhausting explode 
exploding explosive explosion 
failure failures faint 
fainting fatigue fatigued 
fatiguing fatigues fetal circulation 
fever fevers flush 
flushed flushes flushing 
fracture fractures gas 
gaseous gassy gastritis 
hallucinating hallucinations headache 
headaches heartburn hepatitis c 
hcv hive hives 
horrible horrific horrifying 





hurts hurting hyperactive 
hyperglycemia hyperkalemia hypertension 
hypoglycemia hypotension ill 
illness impair impaired 
impairs impairing impotence 
impotent impulsive inability 
unable increase increased 
increasing indigestion infect 
infected infection infects 
infections inflamation inflamed 
inflame injure injury 
injuries injured insomnia 
interaction interactions interval 
intervals irreparable irreversible 
irritable irritate irritated 
irritability irritates itch 
itching itchy itches 
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jaundice ketoacidosis leukemia 
leukoencephalopathy leukodystrophy loss 
losses lymphoma malignancies 
malignancy malignant melanoma 
mellitus miscarriage mortified 
murmur murmurs myopathy 
myopathic nausea nauseous 
nervousness neuropathy numb 
numbness numbing obstructive sleep apnea 
osa pain painful 
pains palpitations pancreatitis 
panicky paresthesia parkinsonism 
persistent pneumonia pounding 










pulmonary hypertension pulsate pulsating 
rapid rapidly rash 
rashes react reaction 
reactions reduce reducing 
reduced reduction reductions 
regulatory regulation regulate 
rhythm rhythms ringing 
runny rupture ruptures 
ruptured rupturing sad 
sadness sclerosis seizure 
seizures seizing sensation 
sensitivity sensitive serious 
seriousness seriously serotonin syndrome 
serotonin toxicity serotonin sickness serotonin poisoning 
severe severely shakiness 
shaky sharp short 
shortness shortening shorter 
sleep sleeping sleepiness 
slept sore soreness 
spasm spasms stroke 
strokes stuffy stuffiness 
congest congested congestion 
sudden sugar glycosylate 
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glycosylated hemoglobin hba1c 
suicidal suicide sweat 
sweats sweating swell 
swelling swollen swells 
syncope tachycardia temper 
tempers tenderness tendonitis 
terrible terrified terrifying 
thrombosis thromboembolism tingle 
tingling tinnitus tired 
tiredness tire torsades de pointes 
ventricular tachycardia toxicity trauma 
traumatic tremor tremors 
tumor tumors tumorous 
ulcer ulcers ulcerative 
unexplained upset irritated 
irritable irritate irritation 
upsetting vaginitis vertigo 
virus viral vomit 
vomits vomiting vomited 
wart warts watery 
weak weaken weakening 
weakness weaknesses weight 
















Correlation of Computed Similarity against Human Ratings 
 















Information Retrieval Factors  
 






Table B.7: Reaction – Top 20 SMAs/VCs. (Ranked by Fm_similar) 
 
 
